(Q39867395)

15 September 2017

Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children (English)

1 reference

15 September 2017

1 reference

5

Blumer JL

1 reference

15 September 2017

Reed MD

1

1 reference

15 September 2017

Goldfarb J

series ordinal

2

1 reference

15 September 2017

Yamashita TS

series ordinal

3

1 reference

15 September 2017

Lemon E

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 December 1994

1 reference

15 September 2017

10

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

15 September 2017

38

1 reference

15 September 2017

12

1 reference

15 September 2017

2817-2826

1 reference

Kinetic interactions of tazobactam with beta-lactamases from all major structural classes

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

New Penicillins and Their Use in Pediatrics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Pharmacokinetics of intravenously administered piperacillin in preadolescent children

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Piperacillin pharmacokinetics in pediatric patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Biliary concentrations of piperacillin in patients undergoing cholecystectomy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Clinical pharmacokinetics in infants and children. A reappraisal

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Human pharmacodynamics of beta-lactams, aminoglycosides and their combination

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

beta-Lactamases of gram-negative bacteria: new challenges for new drugs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Piperacillin: human pharmacokinetics after intravenous and intramuscular administration

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Piperacillin, a new penicillin active against many bacteria resistant to other penicillins

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Meeting the challenges of beta-lactamases

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Developmental pharmacology and therapeutics of piperacillin in gram-negative infections.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

17 June 2018

Piperacillin kinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188291

Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin

17 June 2018

1 reference

12 December 2020

Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease

1 reference

12 December 2020

A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group

1 reference

12 December 2020

Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections

1 reference

12 December 2020

Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study

1 reference

12 December 2020

Susceptibility survey of piperacillin alone and in the presence of tazobactam

1 reference

12 December 2020

Dose Dependence of Piperacillin Pharmacokinetics

1 reference

12 December 2020

The effect of piperacillin dose on elimination kinetics in renal impairment

1 reference

12 December 2020

Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis

1 reference

12 December 2020

Amoxicillin-potassium clavulanate: rational pharmacology meets clinical infectious disease

1 reference

12 December 2020

Therapeutic evaluation of piperacillin for acute pulmonary exacerbations in cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.38.12.2817

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

7695268

1 reference